Optimisation of medications used in residential aged care facilities: a systematic review and meta-analysis of randomised controlled trials.
Aged care facility
Clinical outcomes
Elderly
Intervention
Medication optimisation
Meta-analysis
Systematic review
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
08 07 2020
08 07 2020
Historique:
received:
02
03
2020
accepted:
29
06
2020
entrez:
10
7
2020
pubmed:
10
7
2020
medline:
22
12
2020
Statut:
epublish
Résumé
Frail older adults living in residential aged care facilities (RACFs) usually experience comorbidities and are frequently prescribed multiple medications. This increases the potential risk of inappropriate prescribing and its negative consequences. Thus, optimising prescribed medications in RACFs is a challenge for healthcare providers. Our aim was to systematically review interventions that increase the appropriateness of medications used in RACFs and the outcomes of these interventions. Systematic review and meta-analysis of randomised control trials (RCTs) and cluster randomised control trials (cRCTs) were performed by searching specified databases (MEDLINE, PubMed, Google scholar, PsycINFO) for publications from inception to May 2019 based on defined inclusion criteria. Data were extracted, study quality was assessed and statistically analysed using RevMan v5.3. Medication appropriateness, hospital admissions, mortality, falls, quality of life (QoL), Behavioural and Psychological Symptoms of Dementia (BPSD), adverse drug events (ADEs) and cognitive function could be meta-analysed. A total of 25 RCTs and cRCTs comprising 19,576 participants met the inclusion criteria. The studies tested various interventions including medication review (n = 13), staff education (n = 9), multi-disciplinary case conferencing (n = 4) and computerised clinical decision support systems (n = 2). There was an effect of interventions on medication appropriateness (RR 0.71; 95% confidence interval (CI): 0.60,0.84) (10 studies), and on medication appropriateness scales (standardised mean difference = - 0.67; 95% CI: - 0.97, - 0.36) (2 studies). There were no apparent effects on hospital admission (RR 1.00; 95% CI: 0.93, 1.06), mortality (RR 0.98; 95% CI: 0.86, 1.11), falls (RR 1.06; 95% CI: 0.89,1.26), ADEs (RR 1.04; 95% CI: 0.96,1.13), QoL (standardised mean difference = 0.16; 95% CI:-0.13, 0.45), cognitive function (weighted mean difference = 0.69; 95% CI: - 1.25, 2.64) and BPSD (RR 0.68; 95% CI: 0.44,1.06) (2 studies). Modest improvements in medication appropriateness were observed in the studies included in this systematic review. However, the effect on clinical measures was limited to drive strong conclusions.
Sections du résumé
BACKGROUND
Frail older adults living in residential aged care facilities (RACFs) usually experience comorbidities and are frequently prescribed multiple medications. This increases the potential risk of inappropriate prescribing and its negative consequences. Thus, optimising prescribed medications in RACFs is a challenge for healthcare providers.
OBJECTIVE
Our aim was to systematically review interventions that increase the appropriateness of medications used in RACFs and the outcomes of these interventions.
METHODS
Systematic review and meta-analysis of randomised control trials (RCTs) and cluster randomised control trials (cRCTs) were performed by searching specified databases (MEDLINE, PubMed, Google scholar, PsycINFO) for publications from inception to May 2019 based on defined inclusion criteria. Data were extracted, study quality was assessed and statistically analysed using RevMan v5.3. Medication appropriateness, hospital admissions, mortality, falls, quality of life (QoL), Behavioural and Psychological Symptoms of Dementia (BPSD), adverse drug events (ADEs) and cognitive function could be meta-analysed.
RESULTS
A total of 25 RCTs and cRCTs comprising 19,576 participants met the inclusion criteria. The studies tested various interventions including medication review (n = 13), staff education (n = 9), multi-disciplinary case conferencing (n = 4) and computerised clinical decision support systems (n = 2). There was an effect of interventions on medication appropriateness (RR 0.71; 95% confidence interval (CI): 0.60,0.84) (10 studies), and on medication appropriateness scales (standardised mean difference = - 0.67; 95% CI: - 0.97, - 0.36) (2 studies). There were no apparent effects on hospital admission (RR 1.00; 95% CI: 0.93, 1.06), mortality (RR 0.98; 95% CI: 0.86, 1.11), falls (RR 1.06; 95% CI: 0.89,1.26), ADEs (RR 1.04; 95% CI: 0.96,1.13), QoL (standardised mean difference = 0.16; 95% CI:-0.13, 0.45), cognitive function (weighted mean difference = 0.69; 95% CI: - 1.25, 2.64) and BPSD (RR 0.68; 95% CI: 0.44,1.06) (2 studies).
CONCLUSION
Modest improvements in medication appropriateness were observed in the studies included in this systematic review. However, the effect on clinical measures was limited to drive strong conclusions.
Identifiants
pubmed: 32641005
doi: 10.1186/s12877-020-01634-4
pii: 10.1186/s12877-020-01634-4
pmc: PMC7346508
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
236Subventions
Organisme : Medical Research Future Fund Next Generation Clinical Researchers Practitioner Fellowship
ID : 1155669
Pays : International
Organisme : University of Western Australia International Fee Scholarship (Uifs) And University Postgraduate Award (Upa).
ID : 2019
Pays : International
Références
Drugs Aging. 2012 Jun 1;29(6):437-52
pubmed: 22642779
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Lancet. 2007 Jul 14;370(9582):173-184
pubmed: 17630041
BMJ. 2006 Apr 1;332(7544):756-61
pubmed: 16543297
PLoS One. 2016 Mar 04;11(3):e0149984
pubmed: 26942907
Drug Saf. 2016 Feb;39(2):109-16
pubmed: 26692396
J Am Geriatr Soc. 1996 Jan;44(1):7-13
pubmed: 8537594
Clin Drug Investig. 1998;16(6):441-52
pubmed: 18370559
J Am Med Inform Assoc. 2009 Jul-Aug;16(4):480-5
pubmed: 19390107
J Clin Pharm Ther. 2007 Apr;32(2):113-21
pubmed: 17381661
Age Ageing. 2006 Nov;35(6):586-91
pubmed: 16905764
J Am Med Dir Assoc. 2014 Dec;15(12):892-8
pubmed: 24814043
Drugs Aging. 2013 Apr;30(4):235-46
pubmed: 23408163
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Implement Sci. 2016 Mar 11;11:35
pubmed: 26968520
Cochrane Database Syst Rev. 2016 Feb 12;2:CD009095
pubmed: 26866421
Br J Clin Pharmacol. 2001 Mar;51(3):257-65
pubmed: 11298072
Cochrane Database Syst Rev. 2014 Oct 07;(10):CD008165
pubmed: 25288041
Am J Geriatr Pharmacother. 2004 Dec;2(4):257-64
pubmed: 15903284
N Engl J Med. 1992 Jul 16;327(3):168-73
pubmed: 1608408
J Am Geriatr Soc. 1998 Jan;46(1):77-82
pubmed: 9434669
Br J Psychiatry. 2000 Jun;176:563-7
pubmed: 10974963
Ann Pharmacother. 1998 Jan;32(1):27-32
pubmed: 9475816
J Clin Psychiatry. 2010 Jan;71(1):80-6
pubmed: 20129008
Ther Adv Chronic Dis. 2011 Nov;2(6):353-8
pubmed: 23251760
BMC Geriatr. 2011 Apr 17;11:16
pubmed: 21496345
BMC Geriatr. 2009 Jan 28;9:5
pubmed: 19175914
J Am Med Dir Assoc. 2014 Dec;15(12):885-91
pubmed: 24895001
BMC Health Serv Res. 2004 Apr 06;4(1):6
pubmed: 15066200
Age Ageing. 2011 Mar;40(2):150-62
pubmed: 21262782
J Gerontol A Biol Sci Med Sci. 2013 Mar;68(3):271-8
pubmed: 22982689
J Am Geriatr Soc. 2014 Sep;62(9):1658-65
pubmed: 25243680
Age Ageing. 2004 Nov;33(6):612-7
pubmed: 15385274
Drugs Aging. 2019 Mar;36(3):247-267
pubmed: 30565157
J Am Geriatr Soc. 2011 Jul;59(7):1238-45
pubmed: 21649623
J Am Geriatr Soc. 2008 Dec;56(12):2225-33
pubmed: 19093922
Age Ageing. 2011 May;40(3):307-12
pubmed: 20817937
Med Care. 2001 May;39(5):436-45
pubmed: 11317092
J Am Geriatr Soc. 1997 Feb;45(2):207-10
pubmed: 9033521
J Am Geriatr Soc. 2010 Jan;58(1):44-53
pubmed: 20002510
J Am Med Dir Assoc. 2015 Jan;16(1):49-55
pubmed: 25239019